Serveur d'exploration Tocilizumab - Exploration (Accueil)

Index « Titre (en) » - entrée « development »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
developing < development < developments  Facettes :

List of bibliographic references indexed by development

Number of relevant bibliographic references: 72.
[0-20] [0 - 20][0 - 50][20-40]
Ident.Authors (with country if any)Title
000199 (2020) Tarek Mohamed Abd El-Aziz [États-Unis, Égypte] ; James D. Stockand [États-Unis]Recent progress and challenges in drug development against COVID-19 coronavirus (SARS-CoV-2) - an update on the status
000211 (2020) Keith W. Kelley [États-Unis] ; Yu-Ping Peng [République populaire de Chine] ; Quentin Liu [République populaire de Chine] ; Hui-Chih Chang [Taïwan] ; Sarah J. Spencer [Australie] ; Mark R. Hutchinson ; Atsuyoshi Shimada [Japon]Psychoneuroimmunology goes East: Development of the PNIRSChina affiliate and its expansion into PNIRSAsia-Pacific
000220 (2020) Jamie E. Collins ; Fredrik D. Johansson ; Sara Gale ; Seoyoung Kim ; Swastina Shrestha ; David Sontag ; Jacklyn Stratton ; Huong Trinh ; Chang Xu ; Elena Losina ; Daniel H. SolomonPredicting Remission Among Patients With Rheumatoid Arthritis Starting Tocilizumab Monotherapy: Model Derivation and Remission Score Development
000441 (2020) Ruei-Min Lu [Taïwan] ; Yu-Chyi Hwang [Taïwan] ; I-Ju Liu [Taïwan] ; Chi-Chiu Lee [Taïwan] ; Han-Zen Tsai [Taïwan] ; Hsin-Jung Li [Taïwan] ; Han-Chung Wu [Taïwan]Development of therapeutic antibodies for the treatment of diseases
000500 (2020) Ricardo L. B. Costa ; Brian J. CzernieckiClinical development of immunotherapies for HER2+ breast cancer: a review of HER2-directed monoclonal antibodies and beyond
000591 (2020) Xian Zhang [République populaire de Chine] ; Jing-Jing Li [République populaire de Chine] ; Pei-Hua Lu [République populaire de Chine]Advances in the development of chimeric antigen receptor-T-cell therapy in B-cell acute lymphoblastic leukemia
000655 (2019) Takuya Inoue [Japon] ; Masataka Kohno [Japon] ; Hidetake Nagahara [Japon] ; Ken Murakami [Japon] ; Tomoya Sagawa [Japon] ; Akiko Kasahara [Japon] ; Shunya Kaneshita [Japon] ; Takashi Kida [Japon] ; Kazuki Fujioka [Japon] ; Makoto Wada [Japon] ; Hiroshi Nakada [Japon] ; Timothy Hla [États-Unis] ; Yutaka Kawahito [Japon]Upregulation of sphingosine-1-phosphate receptor 3 on fibroblast-like synoviocytes is associated with the development of collagen-induced arthritis via increased interleukin-6 production
000728 (2019) Liyang Gu [Oman] ; Shuang YeTocilizumab Cannot Prevent the Development of Bronchiolitis Obliterans in Patients With Castleman Disease-Associated Paraneoplastic Pemphigus.
000771 (2019) Eijiro Jimi [Japon] ; Nana Takakura ; Fumitaka Hiura ; Ichiro Nakamura ; Shizu Hirata-TsuchiyaThe Role of NF-κB in Physiological Bone Development and Inflammatory Bone Diseases: Is NF-κB Inhibition “Killing Two Birds with One Stone”?
000834 (2019) Jose M. Sánchez-Maldonado [Espagne] ; Rafael Cáliz [Espagne] ; Luz Canet [Espagne] ; Rob Ter Horst [Pays-Bas] ; Olivier Bakker [Pays-Bas] ; Alfons A. Den Broeder [Pays-Bas] ; Manuel Martínez-Bueno [Espagne] ; Helena Canhão [Portugal] ; Ana Rodríguez-Ramos [Espagne] ; Carmen B. Lupia Ez [Espagne] ; María José Soto-Pino [Espagne] ; Antonio García [Espagne] ; Eva Pérez-Pampin [Espagne] ; Alfonso González-Utrilla [Espagne] ; Alejandro Escudero [Espagne] ; Juana Segura-Catena [Espagne] ; Romana T. Netea-Maier [Pays-Bas] ; Miguel Ngel Ferrer [Espagne] ; Eduardo Collantes-Estevez [Espagne] ; Miguel Ngel L Pez Nevot [Espagne] ; Yang Li [Pays-Bas] ; Manuel Jurado [Espagne] ; João E. Fonseca [Portugal] ; Mihai G. Netea [Pays-Bas, Allemagne] ; Marieke J. H. Coenen [Pays-Bas] ; Juan Sainz [Espagne]Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium
000A39 (2019) Sharin E. Roth ; Mark I. Avigan ; David Bourdet ; David Brott ; Rachel Church ; Ajit Dash ; Douglas Keller ; Philip Sherratt ; Paul B. Watkins ; Lucas Westcott-Baker ; Silvia Lentini ; Michael Merz ; Lila Ramaiah ; Shashi K. Ramaiah ; Ann Marie Stanley ; John MarcinakNext‐Generation DILI Biomarkers: Prioritization of Biomarkers for Qualification and Best Practices for Biospecimen Collection in Drug Development
000B86 (2019) Aroon D. Hingorani [Royaume-Uni] ; Valerie Kuan [Royaume-Uni] ; Chris Finan [Royaume-Uni] ; Felix A. Kruger [Royaume-Uni] ; Anna Gaulton [Royaume-Uni] ; Sandesh Chopade [Royaume-Uni] ; Reecha Sofat [Royaume-Uni] ; Raymond J. Macallister [Royaume-Uni] ; John P. Overington [Royaume-Uni] ; Harry Hemingway [Royaume-Uni] ; Spiros Denaxas [Royaume-Uni] ; David Prieto [Royaume-Uni, Espagne] ; Juan Pablo Casas [États-Unis]Improving the odds of drug development success through human genomics: modelling study
000C51 (2019) Eleftherios Pelechas [Grèce] ; Alexandra Papoudou-Bai [Grèce] ; Paraskevi V. Voulgari [Grèce] ; Alexandros A. Drosos [Grèce]Granuloma annulare development in a patient with rheumatoid arthritis treated with tocilizumab: case-based review.
000D70 (2019) Tadamitsu Kishimoto [Japon]Discovery of IL-6 and Development of Anti-IL-6R Antibody.
000D81 (2019) Margit Boshuizen ; Robin Van Bruggen ; Sebastian A. Zaat ; Marcus J. Schultz ; Eli Aguilera [Espagne] ; Ana Motos [Espagne] ; Tarek Senussi [Espagne, Italie] ; Francesco Antonio Idone [Espagne] ; Paolo Pelosi [Italie] ; Antonio Torres [Espagne] ; Gianluigi Li Bassi [Espagne] ; Nicole P. JuffermansDevelopment of a model for anemia of inflammation that is relevant to critical care
000D82 (2019) Hisashi Sasaki [Japon] ; Jun Miyata [Japon] ; Yohei Maki [Japon] ; Yoshifumi Kimizuka [Japon] ; Nobuyoshi Hayashi [Japon] ; Yuji Fujikura [Japon] ; Akihiko Kawana [Japon]Development of Allergic Bronchopulmonary Aspergillosis in a Patient with Crohn's Disease
000D83 (2019) Lei Yu ; Chuncui Jia ; Wenrong Yao ; Dening Pei ; Xi Qin ; Chunming Rao ; Junzhi WangDevelopment and Validation of a Reporter-Cell-Line-Based Bioassay for Therapeutic Soluble gp130-Fc
000E62 (2019) Kei Suzuki [Japon] ; Takeshi Matsumoto [Japon] ; Yoshiaki Iwashita [Japon] ; Ken Ishikura [Japon] ; Masaki Fujioka [Japon] ; Hideo Wada [Japon] ; Naoyuki Katayama [Japon] ; Hiroshi Imai [Japon]Clinicopathological features of TAFRO syndrome complicated by acquired hemophilia A and development of cardiopulmonary arrest that were successfully treated with VA-ECMO and tocilizumab.
001114 (2018) Cecilie F. Kjelgaard-Petersen ; Adam Platt ; Martin Braddock ; Martin A. Jenkins ; Kishwar Musa ; Emma Graham ; Thorbj Rn Gantzel ; Gillian Slynn ; Michael E. Weinblatt ; Morten A. Karsdal ; Christian S. Thudium ; Anne-C. Bay-JensenTranslational Biomarkers and Ex Vivo Models of Joint Tissues as a Tool for Drug Development in Rheumatoid Arthritis
001313 (2018) Friedemann Paul [Allemagne] ; Olwen Murphy [États-Unis] ; Santiago Pardo [États-Unis] ; Michael Levy [États-Unis]Investigational drugs in development to prevent neuromyelitis optica relapses.
001340 (2018) Xavier M. Teitsma [Pays-Bas] ; Johannes W G. Jacobs [Pays-Bas] ; Paco M J. Welsing [Pays-Bas] ; Pascal H P. De Jong [Pays-Bas] ; Johanna M W. Hazes [Pays-Bas] ; Angelique E A M. Weel [Pays-Bas] ; Attila Pethö-Schramm [Suisse] ; Michelle E A. Borm [Pays-Bas] ; Jacob M. Van Laar [Pays-Bas] ; Floris P J G. Lafeber [Pays-Bas] ; Johannes W J. Bijlsma [Pays-Bas]Inadequate response to treat-to-target methotrexate therapy in patients with new-onset rheumatoid arthritis: development and validation of clinical predictors.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i -k "development" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Title.i  \
                -Sk "development" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Title.i
   |clé=    development
}}

Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021